secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2021-08-11T23:59:59+00:00
Accession:  0001558370-21-011217
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reneo Pharmaceuticals posts updated corporate slide deck for investor meetings
------------------------------------------------------------------------------

- Presentation available on company website and filed as Exhibit 99.1 to Form 8-K.
- Deck highlights focus on rare genetic mitochondrial diseases.
- No specific financial or clinical data disclosed in the filing itself.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000155837021011217/0001558370-21-011217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000155837021011217/rphm-20210811x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-011217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer